Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

CDSCO Panel Clears Bristol Myers Yervoy for Two New Cancer Indications

Bristol Myers Squibb application for Augtyro for NTRK-Positive Locally Advanced or Metastatic Solid Tumors accepted by USFDA for priority review

Ruchika Sharma15 Feb 2024 11:13 AM IST

Princeton: Bristol Myers Squibb has announced that the U.S. Food and Drug Administration (FDA) has accepted the supplemental New Drug...

Gland Pharma Pashamylaram facility receives GMP compliance certificate from Danish Medicines Agency

Gland Pharma posts Rs 192 crore profit after tax in Q3

Ruchika Sharma15 Feb 2024 10:00 AM IST

New Delhi: Gland Pharma has said its consolidated Profit After Tax (PAT) stood at Rs 192 crore for the December quarter.The drug firm had reported a...

CDSCO approves Jardiance for treatment of adults with chronic kidney disease in India

Ruchika Sharma14 Feb 2024 5:49 PM IST

Mumbai: The national regulatory authority of India, the Central Drugs Standard Control Organisation (CDSCO), has approved Jardiance...

Abbvie gets USFDA approval for updated indication statement for Rinvoq for Inflammatory Bowel Disease

AbbVie concludes acquisition of ImmunoGen

Ruchika Sharma14 Feb 2024 4:36 PM IST

North Chicago, Ill.: AbbVie has announced that it has completed its acquisition of ImmunoGen. With the completion of the acquisition,...

Advent to Sell Zentiva to Private Equity GTCR in USD 4.8 Billion Deal, Closing Expected in 2026

Eris buys 51 percent stake in Swiss Parenterals for Rs 637.5 crore

Ruchika Sharma14 Feb 2024 3:33 PM IST

New Delhi: Eris Lifesciences has said it has acquired a 51 per cent stake in Swiss Parenterals for Rs 637.5 crore.Ahmedabad-based Swiss Parenterals is...

Rajasthan Chemists Warn of Indefinite Strike Over Rs 880 Crore Unpaid Govt Dues

Noccarc raises USD 2 million from IAN, others

Ruchika Sharma14 Feb 2024 1:30 PM IST

New Delhi: Noccarc, an innovative medical devices startup, has successfully raised $2 million in a recent funding round led by Indian Angel...

Natco Pharma gets 7 USFDA observations for Kothur Pharma Division

USFDA successfully concludes inspection at Unichem Labs Ghaziabad facility

Ruchika Sharma14 Feb 2024 12:15 PM IST

Mumbai: Unichem Labs has announced that the United States Food and Drug Administration (USFDA) has successfully concluded inspection without any...

Lupin Expands GLP-1 Portfolio with Galenicum Semaglutide Deal

Lupin unveils Bromfenac Ophthalmic Solution, 0.075% in US

Ruchika Sharma14 Feb 2024 11:30 AM IST

Mumbai: Global pharma major Lupin Limited has announced the launch of Bromfenac Ophthalmic Solution, 0.075%, after having received an approval...

Pfizer Slapped With Rs 8.79 Cr GST Demand Over Alleged ITC Irregularities, Plans Appeal

Pfizer, UT Southwestern collaborate to develop improved RNA Delivery Technologies

Ruchika Sharma13 Feb 2024 4:30 PM IST

Dallas: UT Southwestern Medical Center is partnering with Pfizer Inc. to develop RNA-enhanced delivery technologies for genetic medicine...

Aurobindo Pharma arm Unit IV gets 5 USFDA observations

Dr Reddy's Labs gets USFDA VAI classification for Hyderabad RnD centre

Ruchika Sharma13 Feb 2024 3:00 PM IST

Hyderabad: Dr Reddy's Laboratories has said the US health regulator has granted Voluntary Action Indicated (VAI) classification to its...

CDSCO Panel Approves Updated Package Insert for Takedas Vedolizumab

Takeda Eohilia gets USFDA nod for people aged 11 years and older with eosinophilic esophagitis

Ruchika Sharma13 Feb 2024 1:30 PM IST

Osaka: Takeda has announced that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first and...

JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatment

Gilead Sciences to acquire CymaBay Therapeutics for USD 4.3 billion

Ruchika Sharma13 Feb 2024 12:30 PM IST

Foster City: Gilead Sciences, Inc. and CymaBay Therapeutics, Inc. have announced a definitive agreement under which Gilead will acquire CymaBay...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok